Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Issued
Ratios

Standard Biotools (LAB) Long-Term Debt Issuances (2021 - 2022)

Standard Biotools (LAB) has disclosed Long-Term Debt Issuances for 4 consecutive years, with $25.0 million as the latest value for Q1 2022.

  • Quarterly Long-Term Debt Issuances changed N/A to $25.0 million in Q1 2022 from the year-ago period, while the trailing twelve-month figure was $25.0 million through Dec 2022, changed N/A year-over-year, with the annual reading at $25.0 million for FY2022, 265.6% up from the prior year.
  • Long-Term Debt Issuances for Q1 2022 was $25.0 million at Standard Biotools, up from $10.0 million in the prior quarter.
  • The five-year high for Long-Term Debt Issuances was $25.0 million in Q1 2022, with the low at $10.0 million in Q3 2021.